Infectious Diseases (except HIV/AIDS)
Showing page 203 of 716 pages of list content
-
Cov 2 MS: an automated matrix-independent assay for mass spectrometric detection and measurement of SARS-CoV-2 nucleocapsid protein in infectious patients
This article's authors -
The REinfection in COVID-19 Estimation of Risk (RECOVER) study: Reinfection and serology dynamics in a cohort of Canadian healthcare workers
This article's authors -
The COVID-19 Community Research Partnership: Objectives, Study Design, Baseline Recruitment, and Retention
This article's authors -
Differential antibody production by symptomatology in SARS-CoV-2 convalescent individuals
This article's authors -
Safety and immunogenicity of a live recombinant Newcastle disease virus-based COVID-19 vaccine (Patria) administered via the intramuscular or intranasal route: Interim results of a non-randomized open label phase I trial in Mexico
This article's authors -
Estimation of COVID-19 cases prevented by vaccination in California
This article's authors -
Where is Omicron? Comparison of SARS-CoV-2 RT-PCR and Antigen Test Sensitivity at Commonly Sampled Anatomic Sites Over the Course of Disease
This article's authors -
Safety and immunogenicity of inactivated whole virion vaccine CoviVac against COVID-19: a multicenter, randomized, double-blind, placebo-controlled phase I/II clinical trial
This article's authors -
Model-based estimates of deaths averted and cost per life saved by scaling-up mRNA COVID-19 vaccination in low and lower-middle income countries in the COVID-19 Omicron variant era
This article's authors -
Symptoms and severity in vaccinated and unvaccinated patients hospitalised with SARS-CoV-2 delta (B.1.617.2) variant infection
This article's authors